Preferences of general practitioners and carers of Alzheimer patients regarding the use of neuroleptics for behavioural disorders in Alzheimer's disease.
Gonzalez-Moneo
M J
MJ
CAP S Martí, Institut Català de la Salut, Barcelona, Spain. 28448mgm@comb.es
Simó
M
M
Pie
M
M
Rivero
D
D
D000544:Alzheimer Disease / Q000150:complications / Q000188:drug therapy*; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D017028:Caregivers / Q000523:psychology*; D017144:Focus Groups; D006801:Humans; D007406:Interview, Psychological; D001523:Mental Disorders / Q000150:complications / Q000188:drug therapy*; D010821:Physicians, Family / Q000523:psychology*
D014150:Antipsychotic Agents